Item 7. Management’s Discussion and Analysis
ITEM 7. Management’s Discussion
And Analysis Of Financial Condition And Results Of Operations.
Unless the context indicates otherwise, references
in this Item to “Intermediate,” “we,” “us,” “our” and similar terms refer to Bluescape
Clean Fuels Intermediate Holdings, LLC and its subsidiaries prior to the consummation of the Business Combination and Verde Clean Fuels,
Inc. (f/k/a CENAQ Energy Corp.) and its subsidiaries after the consummation of the Business Combination. References to “CENAQ”
refer to the predecessor registrant prior to the consummation of the Business Combination. The following discussion and analysis provides
information which we believe is relevant to an assessment and understanding of CENAQ’s results of operations and financial condition.
This discussion and analysis should be read together with the audited consolidated financial statements and related notes of CENAQ that
are included elsewhere in this Report. In addition to historical financial information, this discussion and analysis contains forward-looking
statements based upon current expectations that involve risks, uncertainties and assumptions. See the sections entitled “Cautionary
Note Regarding Forward-Looking Statements” and Item 1A. “Risk Factors” elsewhere in this Report. Actual results and
timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of various factors,
including those set forth under Item 1A. “Risk Factors.”
Overview
During the year ended December 31, 2022 and prior
to the Business Combination, CENAQ was a blank check company incorporated for the purpose of effecting a merger, share exchange, asset
acquisition, share purchase, reorganization or similar business combination with one or more businesses. For more information on the Business
Combination, see the section entitled “Explanatory Note” elsewhere in this Report.
Our Business After the Business Combination
Following the Business Combination, Verde Clean
Fuels is a renewable energy company specializing in the conversion of synthesis gas, or syngas, derived from diverse feedstocks, such
as biomass, municipal solid waste (“MSW”) and mixed plastics, as well as natural gas (including synthetic natural gas) and
other feedstocks, into liquid hydrocarbons that can be used as gasoline through an innovative and proprietary liquid fuels technology,
the STG+® process. Through our STG+® process, we convert syngas into Reformulated Blend-stock for Oxygenate Blending (“RBOB”)
gasoline. We are focused on the development of technology and commercial facilities aimed at turning waste and other bio-feedstocks into
a usable stream of syngas which is then transformed into a single finished fuel, such as gasoline, without any additional refining steps.
The availability of biogenic MSW and the economic and environmental drivers that divert these materials from landfills will enable us
to utilize these waste streams to produce renewable gasoline from modular production facilities with expected capacity to produce between
approximately seven million to 30 million gallons of renewable gasoline per year.
We are redefining liquid fuels technology through
our proprietary and innovative STG+® process to deliver scalable and cost-effective renewable gasoline. We acquired our STG+®
technology from Primus Green Energy (“Primus”), a company established in 2007 that developed the patented STG+® technology
to convert syngas into gasoline or methanol. Since acquiring the technology, we have adapted the application of our STG+® technology
to focus on the renewable energy industry. This adaptation requires a third-party gasification system to produce acceptable synthesis
gas from these renewable feedstocks. Our proprietary STG+® system converts the syngas into gasoline.
We have made significant progress towards commercializing
the first STG+® based commercial production facility in the United States. Our first commercial production facility, which we expect
to be operational by the first half of 2025, will be in Maricopa, Arizona. In the first phase we expect this facility to produce approximately
7 million gallons of renewable gasoline in the first full year of operations. In the second phase, which we expect to be operational in
2026, we anticipate producing approximately 30 million gallons per year of renewable gasoline. Additionally, we have several additional
renewable gasoline projects, and flare mitigating natural gas to gasoline project, in various early stages of development.
39
Over $110 million has been invested in our technology,
including our demonstration facility in New Jersey, which has completed over 10,500 hours of operation producing gasoline or methanol.
Our demonstration facility represents the scalable nature of our operational modular commercial design which has fully integrated reactors
and recycle lines and is designed with key variables, like gas velocity and catalyst bed length, at a 1-to-1 scale with our commercial
design. We have also participated in carbon lifecycle studies to validate the CI score and reduced lifecycle emissions of our renewable
gasoline as well as fuel, blending and engine testing to validate the specification and performance of our gasoline product. We believe
our renewable gasoline exhibits a significant lifecycle carbon emissions reduction compared to traditional petroleum-based gasoline. As
a result, we believe our gasoline produced from renewable feedstock, such as biomass, will qualify under the RFS for the D3 RIN (a carbon
credit), which can have significant value. Similarly, gasoline produced from our process may also qualify for various state carbon programs,
including California’s LCFS. Unlike many other gas-to-liquids technologies, not only can our STG+® process produce renewable
gasoline from syngas, but we expect it will be able to be applied at other production facilities to produce other end products including
methanol. In addition to our initial focus on the production of renewable gasoline, there is opportunity to continue to develop additional
process technology to produce middle distillates including sustainable diesel and sustainable aviation fuel. As of December 31, 2022,
the Company has not derived revenue from its principal business activities. The Company is managed as an integrated business and consequently,
there is only one reportable segment. However, as with other government programs the use requirements of the RFS program and similar state-level
programs are subject to change, which could materially harm our ability to operate profitably.
Recent Developments
On February 15, 2023, we completed the proposed
business combination as per the terms of the Business Combination Agreement. In addition, pursuant to Subscription Agreements entered
into with certain accredited and institutional investors in connection with the Business Combination, concurrently with the Closing of
the Business Combination, we received $32,000,000 in proceeds from the PIPE Investors, in exchange for which we issued 3,200,000 shares
of our Class A Common Stock issued to the PIPE Investors.
After giving effect to the Business Combination,
the redemption of shares of CENAQ’s Class A common stock as described below, the consummation of the PIPE Investment, and the separation
of the former CENAQ units, there are currently (i) 9,358,620 shares of our Class A Common Stock issued and outstanding, (ii) 22,500,000
shares of Class C Common Stock issued and outstanding (shares of Class C Common Stock do not have any economic value but entitle the holder
thereof to one vote per share) and (iii) no shares of Preferred Stock issued and outstanding.
The Class A Common Stock and Warrants commenced
trading on Nasdaq under the symbols “VGAS” and “VGASW,” respectively, on February 16, 2023, subject to ongoing
review of our satisfaction of all listing criteria following the Business Combination.
An aggregate of approximately $158.8 million was
paid from the trust account to holders that properly exercised their right to have their shares of CENAQ’s Class A common stock
redeemed, and the remaining balance immediately prior to the Closing of approximately $19.0 million remained in the trust account.
Key Factors and Trends Influencing our Results of Operations After
the Business Combination
We believe that our performance and future success depend on a number
of factors that present significant opportunities for us but also pose risks and challenges, including competition from other carbon-based
and other non-carbon-based fuel producers, changes to existing federal and state level low-carbon fuel credit systems, and other factors
discussed under the section titled “Risk Factors.” We believe the factors described below are key to our success.
Commencing and Expanding Commercial Operations
In April 2022, we commenced a pre-FEED study for our first commercial
production facility, and we are actively engaged in activities associated with securing the location, feedstock, utility interconnections,
and front-end gasification for our first commercial facility. We believe our commercialization activities are being completed at a pace
that can support first commercial production of renewable gasoline as early as 2024.
We have three additional production facilities planned and four additional
identified potential production facility development opportunities. We believe the number of planned and identified potential production
facilities bode well for our potential future success.
40
Successful Implementation of the first commercial facility
A critical step in our success will be the successful construction
and operation of the first commercial production facility using our patented STG+® technology. We expect that the first commercial
production facility could be operational as early as 2024.
Protection and Continuous Development Of Our Patented Technology
Our ability to compete successfully will depend on our ability to protect,
commercialize, and further develop our proprietary process technology and commercial facilities in a timely manner, and in a manner technologically
superior to and/or are less expensive than competing processes.
Key Components of Results of Operations
We are an early-stage company and our historical
results may not be indicative of our future results. Accordingly, the drivers of our future financial results, as well as the components
of such results, may not be comparable to our historical or future results of operations.
Revenue
We have not generated any revenue to date. We
expect to generate a significant portion of our future revenue from the sale of renewable RBOB grade gasoline primarily in markets with
federal and state level low-carbon fuel credit systems.
Expenses
General and Administrative Expense
G&A expenses consist of compensation costs
for personnel in executive, finance, accounting, and other administrative functions. G&A expenses also include legal fees, professional
fees paid for accounting, auditing and consulting services, and insurance costs. Following the Business Combination, we expect we will
incur higher G&A expenses for public company costs such as compliance with the regulations of the SEC and the Nasdaq Capital Market.
Research and Development Expense
Our research and development (“R&D”)
expenses consist primarily of internal and external expenses incurred in connection with our R&D activities. These expenses include
labor directly performed on our projects and fees paid to third parties working on and testing specific aspects of our STG+ design and
gasoline product output. R&D costs have been expensed as incurred. We expect R&D expenses to grow as we continue to develop the
STG+ technology and develop market and strategic relationships with other businesses.
Income Tax Effects
We are a limited liability company that is treated
as a partnership for tax purposes, with each of our members accounting for its share of tax attributes and liabilities. Accordingly, there
are no current or deferred income tax amounts recorded in our financial statements.
Results of Operations of CENAQ
CENAQ’s entire activities since June 24,
2020 (inception) through December 31, 2022 related to its formation and Public Offering, and, since the completion of the IPO, searching
for a target to consummate a Business Combination and consummating the Business Combination. As of December 31, 2022, CENAQ had neither
engaged in any operations nor generated any revenues. CENAQ generated non-operating income in the form of interest income on cash and
cash equivalents and on marketable securities held in a trust account (the “Trust Account”). CENAQ incurred expenses as a
result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence and
merger and acquisition expenses in connection with completing the Business Combination.
For the year ended December 31, 2022,
CENAQ had a net loss of $3,698,144. CENAQ incurred $5,715,022 of general and administrative expenses, which includes $4,847,741 in costs
related to identifying a target business. CENAQ also incurred $7,363 of interest expense on promissory note from related party and $431,632
of provision for income taxes. We earned interest income of $2,455,873.
For the year ended December 31, 2021, CENAQ had
a net loss of $474,585. CENAQ incurred $456,765 of formation and operating costs (not charged against stockholders’ equity), consisting
mostly of general and administrative expenses. CENAQ earned interest income of $4,680 and recorded unrealized loss on fair value changes
of over-allotment option liability of $22,500.
41
Liquidity and Capital Resources of CENAQ
On August 17, 2021, CENAQ consummated its IPO
of 15,000,000 units, at $10.00 per unit, generating total gross proceeds of $150.0 million and incurring offering costs of approximately
$17.8 million, inclusive of approximately $6.0 million in deferred underwriting commissions. Subsequently, in connection with the Business
Combination, the underwriters agreed to reduce the deferred underwriting discounts and commissions to approximately $4.3 million. Simultaneously
with the closing of the IPO, pursuant to the securities subscription agreement that CENAQ entered into with the CENAQ Sponsor, CENAQ completed
a private placement of 4,500,000 private placement warrants issued to the CENAQ Sponsor and 1,500,000 private placement warrants issued
to CENAQ’s underwriters, generating gross proceeds of $6,000,000. In connection with the closing of the IPO, the CENAQ Sponsor sold
membership interest reflecting an allocation of 75,000 founder shares, or an aggregate of 825,000 founder shares, to each anchor investor
at their original purchase price of approximately $0.0058 per share.
On August 19, 2021, the underwriters’ over-allotment
option was exercised in full, and CENAQ consummated the sale of an additional 2,250,000 units, generating additional proceeds of $22,500,000.
Simultaneously with the closing of the sale of additional units, CENAQ consummated the sale of an additional 675,000 private placement
warrants, generating gross proceeds of $675,000. A total of $174,225,000 from the net proceeds from the IPO and the private placement
were placed in the Trust Account, maintained by Continental Stock Transfer & Trust Company, acting as trustee, and approximately $0.6
million of such net proceeds were deposited in CENAQ’s operating account to pay expenses in connection with the closing of the IPO
and for working capital following IPO.
As of December 31, 2022, CENAQ had $127,965 in
its operating bank account, and working capital deficit of $7,072,012. Subsequent to December 31, 2022, CENAQ used such funds not held
in the Trust Account structuring, negotiating and consummating the Business Combination.
Prior to the Business Combination, CENAQ’s
liquidity needs were satisfied through (i) receipt of a $25,000 capital contribution from the CENAQ Sponsor in exchange for the issuance
of Founder Shares to the CENAQ Sponsor, (ii) the loan under a promissory note with the CENAQ Sponsor of approximately $88,333, (iii) the
unsecured promissory note with the CENAQ Sponsor of $125,000 and (iv) the net proceeds of $600,000 from the private placement of private
placement warrants held outside of the Trust Account. CENAQ fully repaid the promissory notes on August 17, 2021 and February 15, 2023.
On May 31, 2022, the Sponsor agreed
to loan the Company $125,000 pursuant to a promissory note (the “Promissory Note”). The Promissory Note bears an interest
of 10% per annum, payable on the earlier of (i) February 17, 2023 or (ii) the closing date on which the Company consummates an initial
business combination. There was $125,000 and $0 outstanding under the Promissory Note as of December 31, 2022 and 2021, respectively.
Such amounts are included in Proceeds from note payable-related party on the Consolidated Balance Sheets.
As described in Note 5 to the December 31, 2022
audited Consolidated Financial Statements, in connection with the $1,725,000 extension deposit previously noted, on November 15, 2022,
CENAQ issued an unsecured promissory note (the “Extension Note”) in the principal amount of $1,725,000 to CENAQ Sponsor in
connection with the Extension. The Extension Note was non-interest bearing and was due and payable at the Closing with the amount to be
repaid dependent on the amount of redemptions from the Trust Account at Closing. The amount to be repaid was to be reduced by an amount
equal to the percentage of redemptions multiplied by $1,725,000. There was $1,725,000 and $0 outstanding under the Extension Note as of
December 31, 2022 and 2021, respectively. Such amounts are included in Proceeds from note payable-related party on the Consolidated Balance
Sheets.
42
On November 15, 2022, CENAQ issued
an unsecured promissory note (the “Sponsor Note”) allowing the Company to borrow from the CENAQ Sponsor up to $467,500. Amounts
drawn under the Sponsor Note bear no interest and are due and payable upon the earlier to occur of (i) the date on which CENAQ’s
initial business combination is consummated and (ii) the liquidation of the Company on or before February 16, 2023 or such later liquidation
date as may be approved by the Company’s stockholders. On November 15, 2022, the Company requested and received $100,000 under the
Sponsor Note. There was $100,000 and $0 outstanding under the Sponsor Note as of December 31, 2022 and 2021, respectively. Such amounts
are included in Proceeds from note payable-related party on the Consolidated Balance Sheets.
In order to finance transaction costs in connection
with a Business Combination, the CENAQ Sponsor or an affiliate of the CENAQ Sponsor or certain of CENAQ’s officers and directors
committed to provide CENAQ with Working Capital Loans up to $1,500,000, as defined later (see Note 5). This commitment extends through
February 16, 2023. As of December 31, 2022 and 2021, there were no amounts outstanding under any Working Capital Loans.
In connection with the Closing, and based on the
$158,797,476 of redemptions, CENAQ Sponsor was due $184,612 under the Extension Note. At closing, CENAQ Sponsor was also due $100,000
under the Sponsor Note and $125,000 under the Promissory Note. However, on February 15, 2023, in lieu of repayment of the Extension Note
and repayment of the Sponsor Note and Promissory Note, CENAQ entered into a new promissory note with the Sponsor totaling $409,612 (“New
Promissory Note”). The New Promissory Note, cancels and supersedes the Extension Note and the Sponsor Note. The New Promissory note
is non-interest bearing and the entire principal balance of the New Promissory Note is payable on or before February 15, 2024. The New
Promissory Note is payable at Verde Clean Fuel’s election in cash or in Class A Common Stock at a conversion price of $10.00 per
share.
CENAQ also obtained additional transaction expense
reductions leading up to the Closing including a reduction to the deferred underwriting fees and a reduction to legal expenses. In connection
with the execution of the Business Combination Agreement, on August 12, 2022, the Company, Intermediate and Holdings entered into a letter
agreement with the underwriters, pursuant to which, among other things, (i) Imperial Capital, LLC agreed to forfeit all of its 1,423,125
Private Placement Warrants and all of its 156,543 Representative Shares, (ii) I-Bankers Securities, Inc. agreed to forfeit all of its
301,875 Private Placement Warrants and all of its 33,207 Representative Shares and (iii) the underwriters agreed to reduce their deferred
underwriting fees related to the IPO from $6,037,500 to $4,312,500. As part of the Closing, the underwriters agreed to further reduce
their deferred underwriting fees related to the IPO from $4,312,500 to $1,700,000. Additionally, as of December 31, 2022, CENAQ had $4,110,755
of accrued legal expenses related to the Closing (included in Accounts payable and accrued expenses) and $511,760 of legal expenses recorded
to Deferred financing costs related to the PIPE capital raise. In connection with the Closing, CENAQ received an invoice for actual
legal expenses of $3,250,000. The underwriter’s counsel involved in the PIPE capital raise also agreed, in connection
with Closing, to reduce total legal expenses included in deferred financing costs to $325,000.
The Company’s future liquidity requirements
are satisfied by the net $37,329,178 of cash proceeds received on February 15, 2023 in connection with the Closing.
In connection with the Company’s assessment
of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures
of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company is
able to meet its financial obligations for at least the next year as a result of capital raised in connection with completing the Business
Combination with Verde Clean Fuels on February 15, 2023.
43
Off-Balance Sheet Arrangements; Commitments and Contractual Obligations
of CENAQ
Registration Rights
The holders of the Founder Shares and Private
Placement Warrants (and any shares of Class A Common Stock issuable upon the exercise of the Private Placement Warrants and upon conversion
of the Founder Shares) will be entitled to registration rights pursuant to that certain Registration Rights Agreement, dated August 17,
2021 (the “IPO Registration Rights Agreement”) requiring us to register such securities for resale (in the case of the Founder
Shares, only after conversion to our Class A Common Stock). The holders of the majority of these securities were entitled to make up to
three demands, excluding short form demands, that CENAQ register such securities. In addition, the holders had certain “piggy-back”
registration rights with respect to registration statements filed after the completion of the Business Combination and rights to require
CENAQ to register for resale such securities pursuant to Rule 415 under the Securities Act.
In connection with the Closing, the IPO Registration
Rights Agreement, was amended and restated by Verde Clean Fuels, certain persons and entities holding securities of CENAQ prior to the
Closing (the “Initial Holders”) and certain persons and entities receiving Class A Common Stock and Class C Common Stock pursuant
to the Business Combination (together with the Initial Holders, the “Reg Rights Holders”) (as amended and restated, the “A&R
Registration Rights Agreement”). Pursuant to the A&R Registration Rights Agreement, within 60 days after Closing, Verde Clean
Fuels shall use its commercially reasonable efforts to file with the SEC (at Verde Clean Fuels’ sole cost and expense) a registration
statement registering the resale of certain securities held by or issuable to the Reg Rights Holders (the “Resale Registration Statement”),
and Verde Clean Fuels will use its commercially reasonable efforts to have the Resale Registration Statement declared effective as soon
as reasonably practicable after the filing thereof. In certain circumstances, the Reg Rights Holders can demand Verde Clean Fuels’
assistance with underwritten offerings and block trades, and the Reg Rights Holders are entitled to certain piggyback registration rights.
The A&R Registration Rights Agreement does not provide for the payment of any cash penalties by Verde Clean Fuels if it fails to satisfy
any of its obligations under the A&R Registration Rights Agreement.
Underwriters’ Agreement
CENAQ granted the underwriters a 45-day option
from the date of the Initial Public Offering to purchase up to an additional 2,250,000 units to cover over-allotments, if any. On August
19, 2021, the over-allotments were exercised in full.
Simultaneously with the closing of the Initial
Public Offering and the over-allotment, the underwriters were paid an underwriting discount of 2% of the gross proceeds of the Initial
Public Offering and the over-allotment, or $3,450,000. Additionally, the underwriters were entitled to a deferred underwriting discount
of 3.5% of the gross proceeds of the Initial Public Offering and the over-allotment upon the completion of the Business Combination. Subsequently,
in connection with the Business Combination, the underwriters agreed to reduce the deferred underwriting discount from 3.5% to 2.5%.
On the Closing Date, the deferred fee was paid
from the amounts held in the Trust Account.
Underwriters Letter
In connection with the execution of the Business
Combination Agreement, on August 12, 2022, CENAQ, Intermediate, Holdings and the underwriters entered into the Underwriters Letter, pursuant
to which, among other things, (i) Imperial Capital, LLC agreed to forfeit all of Its 1,423,125 Underwriters Forfeited Warrants and all
of its 156,543 Underwriters Forfeited Shares, (ii) I-Bankers Securities, Inc agreed to forfeit all of its 301,875 Underwriters Forfeited
Warrants and all of its 33,207 Underwriters Forfeited Shares and (iii) the underwriters agreed to reduce their deferred underwriting fees
related to the IPO from $6,037,500 to $4,312,500.
44
Critical Accounting Policies Before the Business Combination
The preparation of consolidated financial statements
and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts
of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and income
and expenses during the periods reported. Making estimates requires management to exercise significant judgment. It is possible that the
estimates management considered could possibly change due to one or more future events. The most significant estimates that affected the
consolidated financial statements as of December 31, 2022 are the calculations of the fair values of the over-allotment option, fair values
of the representative shares and the fair values of the anchor shares. These estimates are uncertain due to the assumptions used in the
stock valuations. These estimates and assumptions have not changed significantly during the year. Actual results could materially differ
from those estimates. We have identified the following as our critical accounting policies:
Offering Costs associated with the Initial Public Offering
Offering costs consist of underwriting, legal,
accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. We comply with the requirements
of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A “Expenses of Offering”. Offering costs
are allocated to the separable financial instruments, if any, issued in the IPO based on a relative fair value basis compared to total
proceeds received.
Class A Common Stock Subject to Possible Redemption
We account for the Class A common stock subject
to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Common stock
subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable
common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other
times, common stock is classified as stockholders’ equity.
We recognize changes in redemption value immediately
as they occur. Immediately upon the closing of the IPO, we recognized the subsequent re-measurement under ASC 480-10-S99 from initial
carrying amount to redemption value. The change in the carrying value of redeemable common stock resulted in charges against additional
paid-in capital and accumulated deficit.
Net Loss Per Common stock
CENAQ had two classes of common stock, which are
referred to as Class A common stock and Class B common stock. Income and losses are allocated on pro rata basis between redeemable and
non-redeemable common stock. The 19,612,500 potential common shares for outstanding warrants to purchase our stock were excluded from
diluted earnings per share for the year ended December 31, 2022 and 2021 because the warrants are contingently exercisable, and the contingencies
have not yet been met. As a result, diluted net loss per common share is the same as basic net loss per common share for the periods.
Recent Accounting Pronouncements
In August 2020, the FASB issued Accounting Standards
Update (“ASU”) No. 2020-06, Debt —debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging
—Contracts in Entity’ Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’
Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required
under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the
derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The guidance was adopted starting
January 1, 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.
45
In May 2021, the FASB issued ASU 2021-04, Earnings
Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718),
and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications
or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force). This guidance
clarifies certain aspects of the current guidance to promote consistency among reporting of an issuer’s accounting for modifications
or exchanges of freestanding equity-classified written call options (for example, warrants) that remain equity classified after modification
or exchange. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including
interim periods within those fiscal years. Early adoption is permitted for all entities, including adoption in an interim period. The
guidance was adopted starting January 1, 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations
or cash flows.
Our management does not believe that any other
recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying financial
statement.
Critical Accounting Policies After the Business Combination
Our consolidated financial statements have been
prepared in conformity with U.S. GAAP as determined by the FASB. The preparation of condensed consolidated financial statements in conformity
with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure
of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses
and allocated charges during the reporting period. The following is a summary of certain critical accounting policies and estimates that
are impacted by judgments and uncertainties and under which different amounts might be reported using different assumptions or estimation
methodologies.
Asset Acquisition
In August 2020, we acquired a demonstration facility,
a laboratory, office space, and intellectual property including the patented STG+® process technology under the terms of a purchase
agreement with Primus Green Energy, Inc. (“Primus”). Upon acquiring the assets of Primus from the Founders, we performed an
assessment as to whether the acquisition should be accounted for as a business combination (under ASC Topic 805) or whether the acquisition
should be accounted for as an asset acquisition under ASC Topic 805-50.
We determined that substantially all of the fair
value of the assets acquired was concentrated in a single identifiable intangible asset representing intellectual property and patented
technology and therefore, the acquisition was not considered the acquisition of a business but rather an asset acquisition. Certain other
ancillary assets were acquired including a property lease and the related leasehold improvements. After allocating the acquisition cost
to physical assets which were deemed immaterial, the remaining value was recorded to a single intangible asset which we referred to as
Intellectual Property and Patented Technology.
We further assessed whether the intangible asset
would be used in Research and Development activities and whether the intangible asset should be capitalized or expensed. Under ASC Topic
730-10, assets that have alternative future uses should be capitalized. An alternative use includes adaptation of an existing capability
to a particular requirement or customer’s need as part of a continuing commercial activity. Another alternative use includes activity,
including design and construction engineering, related to the construction, relocation, rearrangement, or start-up of facilities or equipment
other than facilities or equipment whose sole use is for a particular research and development project.
46
We have utilized the intellectual property and
patented technology, which is considered to be an adaption of an existing capability of the intellectual property and patented technology,
to attempt to meet the contractual requirements of several potential licensing customers including modification to attach our STG+®
process technology to existing customer owned methanol production facilities. Further, we have also utilized the intellectual property
and patented technology acquired to perform additional modifications to the design and engineering of the commercially viable process
island in order to validate the production of other commercially consumed fuels such as diesel and methanol with only minor modifications
to the overall process. As a result of these alternative uses, we concluded the intellectual property and patented technology intangible
asset has alternative future uses and therefore was capitalized.
As a result, substantially all of the asset purchase
price was attributed to the single intangible asset. Accordingly, we recorded $1,925,151 to the intellectual property and patented property
intangible asset inclusive of direct transaction costs of $537,500 that were incurred. The intellectual property and patented technology
is considered an indefinite lived intangible and is not subject to amortization. We expect to reassess the estimated useful life of the
intangible asset following definitive decisions to proceed with the construction of our initial production facility. As of December 31,
2022 and 2021, the gross and carrying amount of the unamortized intellectual property and patented technology intangible asset was $1,925,151.
Contingent Consideration
Holdings, on Intermediate’s behalf, had
an arrangement payable to our Chief Executive Officer and a consultant whereby a contingent payment could become payable in the event
that certain return on investment hurdles are met within five years of the closing date of the Primus asset purchase. At the Closing of
the Business Combination, the Contingent Consideration was forfeited, pursuant to an agreement, dated August 5, 2022, entered into by
Holdings with Intermediate’s management and CEO.
Impairment of Intangible Assets
A qualitative assessment of indefinite-lived intangible
assets is performed in order to determine whether further impairment testing is necessary. In performing this analysis, we consider macroeconomic
conditions, industry and market considerations, current and forecasted financial performance, entity-specific events and changes in the
composition or carrying amount of net assets under the quantitative analysis, intellectual property and patents are tested for impairment
using a discounted cash flow approach and tested for impairment using the relief-from-royalty method. If the fair value of an indefinite-lived
intangible asset is less than its carrying amount, an impairment loss is recognized equal to the difference.
We have considered a mix of information in monitoring
the risks associated with impairment through the use of various valuation analyses which were used to measure the estimated fair value
of our stock-based incentive awards. In addition, the Company considered market transactions (such as the Business Combination). As discussed
above, substantially all of the value of the acquired assets from Primus was attributable to the intellectual property and patented technology.
Such technology has remained our core asset since our acquisition and we have continued to develop such technology and expand its application
to other feedstocks.
47
In connection with our valuation of our stock-based
incentive units granted to management, we determined our estimated enterprise value utilizing a mix of market approach, discounted cash
flow and relief from royalty methods in the determination and such estimated enterprise value exceeded the carrying amount of this intangible
asset by a substantial amount.
During the years ended December 31, 2022 and 2021,
we placed the most weight to the Business Combination in concluding that no impairment testing was required. We also leveraged the valuation
analyses prepared in the measurement of our contingent consideration as discussed in detail above. Such transaction served to support
management’s conclusion that fair value of our indefinite-lived intangible asset is greater than its carrying amount by a substantial
amount, and no impairment charges were recognized in any of the periods presented.
Impairment of Long-Term Assets
We evaluate the carrying value of long-lived assets
when indicators of impairment exist. The carrying value of a long-lived asset is considered impaired when the estimated separately identifiable,
undiscounted cash flows from such asset are less than the carrying value of the asset. In that event, a loss is recognized based on the
amount by which the carrying value exceeds the fair value of the long-lived asset. Fair value is determined primarily using the estimated
cash flows discounted at a rate commensurate with the risk involved. There were no impairment charges in any of the periods presented.
JOBS Act
On April 5, 2012, the JOBS Act was signed into
law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies.
We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements
based on the effective date for private (not publicly traded) companies. CENAQ previously elected to irrevocably opt out of such extended
transition period, which means that when a standard is issued or revised and it has different application dates for public or private
companies, we will adopt the new or revised standard at the time public companies adopt the new or revised standard. This may make comparison
of our consolidated financial statements with another emerging growth company that has not opted out of using the extended transition
period difficult or impossible because of the potential differences in accountant standards used.
Additionally, we are in the process of evaluating
the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth
in the JOBS Act, if, as an “emerging growth company”, we choose to rely on such exemptions we may not be required to, among
other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to
Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank
Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory
audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the consolidated
financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation
between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These
exemptions will apply for a period of five years following the completion of the IPO or until we are no longer an “emerging growth
company,” whichever is earlier.
ITEM 7A. Quantitative and Qualitative
Disclosures about Market Risk.
Pursuant to Item 305(e) of Regulation S-K (§
229.305(e)), the Company is not required to provide the information required by this Item as it is a “ smaller reporting company, ”
as defined by Rule 229.10(f)(1).